More than 30 years after diabetics began injecting themselves with the modern form of insulin, treatments in a pill seem as elusive as ever. Delivery of the hormone in a tablet is still considered the ...

Diabetes drug maker Novo Nordisk said on Friday it had agreed a $1.8 billion deal to acquire Emisphere Technologies, giving it control of a pill technology that it hopes will broaden sales to ...

It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred dollars each month out of pocket ...